CHMP6
Basic information
Region (hg38): 17:80991598-81009517
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHMP6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 14 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 1 | 3 |
Variants in CHMP6
This is a list of pathogenic ClinVar variants found in the CHMP6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-80991953-G-C | not specified | Uncertain significance (Jun 01, 2023) | ||
17-80994609-G-A | not specified | Likely benign (Oct 27, 2021) | ||
17-80994641-G-C | not specified | Uncertain significance (Mar 01, 2023) | ||
17-80994650-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-80994651-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
17-80994653-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-80994662-C-T | not specified | Uncertain significance (Aug 16, 2021) | ||
17-80994675-G-A | not specified | Uncertain significance (Aug 04, 2024) | ||
17-80994680-G-A | Benign (Dec 31, 2019) | |||
17-80995020-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
17-80995026-A-G | not specified | Uncertain significance (Aug 10, 2024) | ||
17-80995081-A-C | not specified | Uncertain significance (Dec 28, 2022) | ||
17-80995672-G-A | not specified | Uncertain significance (May 08, 2024) | ||
17-80995711-A-T | not specified | Uncertain significance (May 14, 2024) | ||
17-80995727-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
17-80995757-A-G | not specified | Uncertain significance (Aug 14, 2024) | ||
17-80997010-A-G | not specified | Uncertain significance (Nov 16, 2022) | ||
17-80997047-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
17-80997058-G-A | not specified | Uncertain significance (Dec 02, 2024) | ||
17-80997071-G-A | not specified | Uncertain significance (Jan 10, 2022) | ||
17-80997264-A-G | not specified | Uncertain significance (Feb 22, 2024) | ||
17-80997298-A-T | not specified | Uncertain significance (Nov 23, 2024) | ||
17-80997348-GC-G | Benign (Oct 19, 2017) | |||
17-80999102-C-T | Benign (Oct 19, 2017) | |||
17-80999116-C-A | not specified | Uncertain significance (Jun 18, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CHMP6 | protein_coding | protein_coding | ENST00000325167 | 8 | 17920 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.984 | 0.0164 | 106653 | 0 | 1 | 106654 | 0.00000469 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.168 | 108 | 113 | 0.955 | 0.00000704 | 1304 |
Missense in Polyphen | 26 | 36 | 0.72222 | 447 | ||
Synonymous | 0.466 | 43 | 47.1 | 0.914 | 0.00000320 | 361 |
Loss of Function | 3.28 | 0 | 12.5 | 0.00 | 5.32e-7 | 151 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000103 | 0.0000103 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. In the ESCRT-III complex, it probably serves as an acceptor for the ESCRT-II complex on endosomal membranes.;
- Pathway
- Endocytosis - Homo sapiens (human);Necroptosis - Homo sapiens (human);Disease;Vesicle-mediated transport;Membrane Trafficking;Budding and maturation of HIV virion;Late Phase of HIV Life Cycle;HIV Life Cycle;HIV Infection;Endosomal Sorting Complex Required For Transport (ESCRT);Infectious disease
(Consensus)
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- loftool
- 0.374
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.04
Haploinsufficiency Scores
- pHI
- 0.273
- hipred
- Y
- hipred_score
- 0.814
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.884
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Chmp6
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- chmp6b
- Affected structure
- anatomical system
- Phenotype tag
- abnormal
- Phenotype quality
- quality
Gene ontology
- Biological process
- nucleus organization;vacuolar transport;mitotic metaphase plate congression;negative regulation of epidermal growth factor-activated receptor activity;protein transport;endosomal transport;macroautophagy;viral life cycle;multivesicular body assembly;viral budding via host ESCRT complex;regulation of protein catabolic process;midbody abscission;regulation of exosomal secretion;ESCRT III complex assembly
- Cellular component
- ESCRT III complex;cytosol;endosome membrane;membrane;late endosome membrane;extracellular exosome
- Molecular function
- protein binding;protein-containing complex binding;protein N-terminus binding